Back

Sellas shares plunge 16.6% in third quarter amid AML trial delays

Verifying
  • Sellas shares fell 16.6% during the third quarter amid uncertainty over AML trial results.
  • Sellas shares closed Wednesday at $12.31, down from $14.76 on June 30.
  • Sellas said it would report GPS data after the 80th patient death.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.